Determination of α-1 Acid Glycoprotein in Patients with Ph+ Chronic Myeloid Leukemia during the First 13 Weeks of Therapy with STI571

By le Coutre P.   Kreuzer K-A.   Na I-K.   Lupberger J.   Holdhoff M.   Appelt C.   Schwarz M.   Müller C.   Gambacorti-Passerini C.   Platzbecker U.   Bonnet R.   Ehninger G.   Schmidt C.A.  

Blood Cells, Molecules, and Diseases, Vol. 28, Iss. 1, 2002-01 ,pp. : 75-85

Academic Press

Access to resources Recommend Favorite

Use of tyrosine kinase inhibitors in a patient with Brugada syndrome and chronic myeloid leukemia

By Sgherza Nicola   Russo Rossi Antonella   Colonna Paolo   Carluccio Paola   Delia Mario   Specchia Giorgina  

International Journal of Hematology, Vol. 98, Iss. 4, 2013-10 ,pp. : 483-486

Springer Publishing Company

Access to resources Recommend Favorite

CD34 + cord blood cells expressing cutaneous lymphocyte-associated antigen are enriched in granulocyte-macrophage progenitors and support extensive amplification of dendritic cell progenitors

By Arrighi J.-F.   Zubler R.   Hauser C.   Irion O.   Brouwers N.   Chapuis B.   Kindler V.  

Experimental Hematology, Vol. 29, Iss. 8, 2001-08 ,pp. : 1029-1037

Elsevier

Access to resources Recommend Favorite

Granulocyte macrophage colonystimulating factor as a predictor of the response of metastatic renal cell carcinoma to tyrosine kinase inhibitor therapy

By                        

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 1023-1027

Spandidos Publications

Access to resources Recommend Favorite

Chronic myelomonocytic leukemia requires granulocyte-macrophage colony-stimulating factor for growth in vitro and in vivo

By Ramshaw H.S.   Bardy P.G.   Lee M.A.   Lopez A.F.  

Experimental Hematology, Vol. 30, Iss. 10, 2002-10 ,pp. : 1124-1131

Elsevier

Access to resources Recommend Favorite